Table 6.

Drugbank molecules predicted to be therapeutic to COVID-19

Molecule	Ranking	Stage	Evidence
DB14761(Remdesivir)	17	Approved; investigational	Approved for COVID-19
DB00481(Raloxifene)	1	Approved; investigational	Hong et al. (2021b)
DB01268(Sunitinib)	3	Approved; investigational	Wang et al. (2020)
DB05420(Gallium maltolate)	5	Investigational	Bernstein and Zhang (2020)
DB13527(Proglumetacin)	6	Experimental	Alves et al. (2021)
DB12181(Dalcetrapib)	13	Investigational	Niesor et al. (2021)
DB11753(Rifamycin)	14	Approved; investigational	Pathak et al. (2021)